EDGAR Filing Documents for 0001558370-24-004996

Form PRE 14A - Other preliminary proxy statements:

SEC Accession No. 0001558370-24-004996

Filing Date

2024-04-12

Accepted

2024-04-12 07:06:47

Documents

Period of Report

2024-06-18

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	PRE 14A	qure-20240618xpre14a.htm iXBRL	PRE 14A	2095857
2	GRAPHIC	qure-20240618xpre14a_a006.jpg	GRAPHIC	10720
3	GRAPHIC	qure-20240618xpre14a_a009.jpg	GRAPHIC	20070
4	GRAPHIC	qure-20240618xpre14a_a015.jpg	GRAPHIC	64891
5	GRAPHIC	qure-20240618xpre14a_a016.jpg	GRAPHIC	67814
6	GRAPHIC	qure-20240618xpre14a_bg001.jpg	GRAPHIC	135914
7	GRAPHIC	qure-20240618xpre14a_bg002.jpg	GRAPHIC	163569
	Complete submission text file	0001558370-24-004996.txt		4103232

Data Files

Seq	Description	Document	Type	Size
8	EX-101.SCH	qure-20240618.xsd	EX-101.SCH	5484
9	EX-101.DEF	qure-20240618_def.xml	EX-101.DEF	6014
10	EX-101.LAB	qure-20240618_lab.xml	EX-101.LAB	12439
11	EX-101.PRE	qure-20240618_pre.xml	EX-101.PRE	6347
24	EXTRACTED XBRL INSTANCE DOCUMENT	qure-20240618xpre14a_htm.xml	XML	234222

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP

Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000

uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36294 | Film No.: 24839959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)